Valley National Advisers’s BioNTech BNTX Stock Holding History

Valley National Advisers’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.49K	Hold	16	–	–	﹤0.01%	836
2026 Q1	$1K	Hold	16	–	–	﹤0.01%	811
2025 Q4	$1K	Hold	16	–	–	﹤0.01%	827
2025 Q3	$1K	Hold	16	–	–	﹤0.01%	769
2025 Q2	$1K	Hold	16	–	–	﹤0.01%	753
2025 Q1	$1K	Hold	16	–	–	﹤0.01%	744
2024 Q4	$1K	Hold	16	–	–	﹤0.01%	709
2024 Q3	$1K	Hold	16	–	–	﹤0.01%	685
2024 Q2	$1K	Hold	16	–	–	﹤0.01%	998
2024 Q1	$1K	Buy	+16	New	+$1.53K	﹤0.01%	1038
2023 Q4	–	Sell	-16	Closed	-$2K	–	1200
2023 Q3	$2K	Hold	16	–	–	﹤0.01%	807
2023 Q2	$2K	Hold	16	–	–	﹤0.01%	769
2023 Q1	$2K	Hold	16	–	–	﹤0.01%	752
2022 Q4	$2K	Hold	16	–	–	﹤0.01%	732
2022 Q3	$2K	Hold	16	–	–	﹤0.01%	772
2022 Q2	$3K	Hold	16	–	–	﹤0.01%	705
2022 Q1	$3K	Hold	16	–	–	﹤0.01%	742
2021 Q4	$4K	Hold	16	–	–	﹤0.01%	702
2021 Q3	$4K	Buy	+16	New	+$5.08K	﹤0.01%	686

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Valley National Advisers's BNTX Position: Q2 2026 in Review

Valley National Advisers held its BioNTech (BNTX) position steady in Q2 2026 at 16 shares worth $1.49K. The position accounts for ﹤0.01% of the portfolio, ranked #836.

Valley National Advisers first reported a position in BNTX in Q3 2021 and has held it in 19 quarters since. The position peaked at $4K in Q4 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Valley National Advisers held 16 shares of BioNTech worth $1.49K as of Q2 2026.
Valley National Advisers left its BioNTech share count unchanged in Q2 2026.
BioNTech made up ﹤0.01% of Valley National Advisers's portfolio in Q2 2026, its #836 holding.
Valley National Advisers first reported a position in BioNTech in Q3 2021 and has held it in 19 quarters since.
Valley National Advisers's BioNTech position peaked at $4K in Q4 2021.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.